Kelly Londy has more than 25 years’ experience in the global healthcare and medical devices industry. She is currently CEO and member of the Board of Directors at Lumicell, a technology company in the field of image-guided cancer surgery. During her two years at Lumicell, she has overseen a successful Series C financing round and the implementation of a development strategy to expand its pipeline across five solid tumour cancers. Prior to this Kelly spent six years at Accuray, where she held Executive roles as Chief Operating Officer and Chief Commercial Officer providing leadership across all customer facing activities. She has also held leadership roles at GE Healthcare and Philips Healthcare.
Camille Farhat is currently President and CEO of RTI Surgical, a global surgical implant company. Prior to his position at RTI Surgical, he served as President and CEO of American Medical Systems and has held broad executive and leadership positions at Baxter International, Medtronic and General Electric. Camille also serves on the Board of Directors of Cardiac Science, the Advanced Medical Technology Association and is a member of Northwestern Memorial Cerebrovascular Neurosurgery Advisory Council. He is a seasoned executive with a recognised track record of transforming, regenerating and commercially growing healthcare businesses globally.
Erik Langaker, Chairman of CMR Surgical, said: “I am delighted to welcome Camille and Kelly to the Board at CMR Surgical, both of whom share our passion for transforming surgery for good. They bring a wealth of transferable knowledge from the medical devices sector, building on the strength and breadth of the Board, which will prove invaluable at this pivotal time in the company’s growth. Their executive experience of working for publicly listed companies, coupled with their knowledge of delivering product innovation in the surgical devices arena, will help us to rapidly progress towards the planned commercialisation and scale up of our Versius system in response to considerable industry interest.”